Overview

Pilot Study of Haloperidol to Treat Critical Illness Delirium

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine whether haloperidol reduces the time on the breathing machine in critically ill patients with delirium.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Denver Health Medical Center
Treatments:
Haloperidol
Haloperidol decanoate